MOREPEN LABORATORIES LTD. - 500288 - Reg. 34 (1) Annual Report.
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed Annual Report for the financial year 2021-2022 along-with notice of 37th Annual General Meeting scheduled to be held on Tuesday, 27th September 2022 at 12.30 p.m. (IST) through Video Conferencing/ Other Audio Video Means. MOREPEN LABORATORIES LTD. - 500288 - Shareholder Meeting-AGM On Tuesday, 27Th September 2022 And Book Closure Information
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed notice of 37th Annual General Meeting ('AGM') of Morepen Laboratories Limited ('the company'), scheduled to be held on Tuesday, 27th September 2022 at 12.30 p.m. (IST) through Video Conferencing/ Other Audio Video Means ('VC'/''OAVM'), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 1st September, 2022, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), regarding loss of share certificate of the company. As required under SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January, 2022, the company shall issue 'Letter of Confirmation' to the shareholder after compliance of requisite formalities. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 29th July, 2022, received from Registrar and Share Transfer Agent of the company (viz., Mas Services Limited), comprising information related to issuance of letter(s) of confirmation against duplicate share certificate in electronic mode, in compliance with SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022. Q1FY23 Quarterly Result Announced for Morepen Laboratories Ltd.
Pharmaceuticals firm Morepen Laboratories Announced Q1FY23 Result : The company had long standing liability of 114.65 cr. as outstanding preference capital issued to the Banks/FI's in the 2003/2004. During the quarter the company has converted the outstanding preference capital in to 2.13 cr. Equity Shares of the Company This was the last leg of CDR and the company now has no payment obligations to Banks/FI's and is a Debt Free Company Business is consolidating after Covid pandemic disturbance and expected to stabilise over next 2-3 quarters. Against peak Covid quarterly revenue of Q1'FY22, the revenues for the current quarter, Q1'FY23, is down by 22% Current quarterly revenue of Rs. 303 Cr., is up 50% from preCovid revenues of Q1'FY20 of Rs. 203 Cr. On a long term basis (ignoring the Covid peaks) business has grown consistently at CAGR of 14% from Q1'FY20-Q1FY23 Muted demand, lower price recovery, higher input costs has impacted the profit margins for last two quarters and the recent Rupee depreciation is adding additional burden on the costs. High inventory levels maintained for some Covid products are expected to be realised slowly in coming quarters. Result PDF MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed the Investors Presentation (Q1'FY23) July, 2022, based on the financial performance of the company for the quarter ended 30th June, 2022. MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Morepen Laboratories Limited
Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors of the company in their meeting held today i.e., Friday, 29th July, 2022 (commenced at 11:15 A.M. and concluded at 1.30 P.M.), have, inter-alia, considered and approved results and other items as enclosed. MOREPEN LABORATORIES LTD. - 500288 - Results-Financial Results For The Quarter Ended June 30, 2022
Outcome of the meeting of the Board of Directors of Morepen Laboratories Limited MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 26th July, 2022, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) regarding loss of share certificate of the company. As required under SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January, 2022, the company shall issue 'Letter of Confirmation' to the shareholder after compliance of requisite formalities. Kindly take note of aforesaid into your records.
